Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
FATE THERAPEUTICS INC See All Filings	D	2020-07-06 15:44:32 UTC
Amount To Be Raised $49,999,989 Associated Brokers / Dealers N/A CIK Number 0001434316 Filed Document 0001434316-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-07-06 15:44:32 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
FATE THERAPEUTICS INC See All Filings	D	2020-04-21 15:24:07 UTC
Amount To Be Raised $50,000,024 Associated Brokers / Dealers N/A CIK Number 0001434316 Filed Document 0001434316-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-04-21 15:24:07 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
FATE THERAPEUTICS INC See All Filings	D	2016-12-07 19:50:03 UTC
Amount To Be Raised $56,749,988 Associated Brokers / Dealers LEERINK PARTNERS LLC CIK Number 0001434316 Filed Document 0001434316-16-000008 Exclusions or Exemptions 506b Accepted Date 2016-12-07 19:50:03 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
FATE THERAPEUTICS INC See All Filings	D	2016-08-19 16:07:15 UTC
Amount To Be Raised $10,290,000 Associated Brokers / Dealers N/A CIK Number 0001434316 Filed Document 0001434316-16-000007 Exclusions or Exemptions 506b Accepted Date 2016-08-19 16:07:15 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
FATE THERAPEUTICS INC See All Filings	D	2015-05-18 00:00:00 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers N/A CIK Number 0001434316 Filed Document 0001434316-15-000006 Exclusions or Exemptions 506b Accepted Date 2015-05-18 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity